AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 137 filers reported holding AVIDITY BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,482,343 | -63.2% | 389,082 | -36.0% | 0.02% | -60.5% |
| Q2 2023 | $6,737,286 | +15.2% | 607,510 | +59.5% | 0.04% | -5.0% |
| Q1 2023 | $5,847,137 | -16.9% | 380,921 | +20.2% | 0.04% | -32.2% |
| Q4 2022 | $7,032,965 | +218.8% | 316,943 | +134.6% | 0.06% | +156.5% |
| Q3 2022 | $2,206,000 | +237.8% | 135,082 | +200.4% | 0.02% | +283.3% |
| Q2 2022 | $653,000 | -54.6% | 44,974 | -42.2% | 0.01% | -33.3% |
| Q1 2022 | $1,437,000 | -5.8% | 77,827 | +21.2% | 0.01% | +12.5% |
| Q4 2021 | $1,526,000 | +49.3% | 64,207 | +54.8% | 0.01% | +14.3% |
| Q3 2021 | $1,022,000 | -14.2% | 41,481 | -13.9% | 0.01% | -12.5% |
| Q2 2021 | $1,191,000 | -10.0% | 48,196 | -20.6% | 0.01% | -11.1% |
| Q1 2021 | $1,324,000 | – | 60,704 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 849,651 | $13,042,143 | 13.77% |
| COWEN AND COMPANY, LLC | 4,592,966 | $70,502,028 | 8.28% |
| Cormorant Asset Management, LP | 2,612,115 | $40,096 | 2.64% |
| 5AM Venture Management, LLC | 665,555 | $10,216,269 | 2.61% |
| RA Capital Management | 6,416,998 | $98,500,919 | 2.23% |
| RTW INVESTMENTS, LP | 6,387,178 | $98,043,182 | 2.04% |
| COMMODORE CAPITAL LP | 590,705 | $9,067,322 | 1.38% |
| Casdin Capital, LLC | 850,000 | $13,047,500 | 1.08% |
| Boxer Capital, LLC | 1,121,327 | $17,212 | 0.85% |
| Octagon Capital Advisors LP | 382,000 | $5,863,700 | 0.84% |